Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment, and you are unlikely to be protected if something goes wrong.

Take two mins to learn more

BiologIC Technologies

BiologIC Technologies

BiologIC Technologies

BiologIC Technologies develops digital and automated platforms to accelerate the design and manufacturing of biologic medicines. Its technology aims to improve efficiency, scalability, and consistency in complex biopharmaceutical production.

BiologIC Technologies develops digital and automated platforms to accelerate the design and manufacturing of biologic medicines. Its technology aims to improve efficiency, scalability, and consistency in complex biopharmaceutical production.

A photo of a man presenting a small scale bio-reactor at an exhibition
A photo of a man presenting a small scale bio-reactor at an exhibition
A photo of a bio-reactor

Why did we invest in

Why did we invest in

BiologIC Technologies

BiologIC Technologies

?

?

  • Proven leadership: Led by biotech veteran Richard Vellacott - track record in scaling and exiting high-growth companies.

  • Large addressable market and high growth: Targeting cell & gene therapy in a biotech sector growing at 13.9% CAGR globally.

  • Novel technology: 3D-printed biocomputer platform - scalable, flexible, and a step-change in automation.

  • Strong traction: Deals with large corporates and a growing commercial pipeline.

  • High-return potential: Clear exit paths via strategic buyers or private equity.

Get in Touch with Our Team.

Get in Touch with Our Team.

Get in Touch with Our Team.

EverQuest Capital Partners Logo

Transforming

industry.

Creating

legacy.

Subscribe to Newsletter

By subscribing you agree that the email provided is subject to our Privacy Policy.

Copyright ©2026. EverQuest Capital Partners

EverQuest Capital Partners LLP; registered in England and Wales (number OC453092).
Authorised and regulated by the Financial Conduct Authority (FRN: 1044826).

Site design by

EverQuest Capital Partners Logo

Transforming

industry.

Creating

legacy.

Subscribe to Newsletter

By subscribing you agree that the email provided is subject to our Privacy Policy.

Copyright ©2026. EverQuest Capital Partners

EverQuest Capital Partners LLP; registered in England and Wales (number OC453092).
Authorised and regulated by the Financial Conduct Authority (FRN: 1044826).

Site design by

EverQuest Capital Partners Logo

Transforming

industry.

Creating

legacy.

Subscribe to Newsletter

By subscribing you agree that the email provided is subject to our Privacy Policy.

Copyright ©2026. EverQuest Capital Partners

EverQuest Capital Partners LLP; registered in England and Wales (number OC453092).
Authorised and regulated by the Financial Conduct Authority (FRN: 1044826).

Site design by